[go: up one dir, main page]

ES8301463A1 - Procedimiento para la produccion de un polipeptido - Google Patents

Procedimiento para la produccion de un polipeptido

Info

Publication number
ES8301463A1
ES8301463A1 ES497113A ES497113A ES8301463A1 ES 8301463 A1 ES8301463 A1 ES 8301463A1 ES 497113 A ES497113 A ES 497113A ES 497113 A ES497113 A ES 497113A ES 8301463 A1 ES8301463 A1 ES 8301463A1
Authority
ES
Spain
Prior art keywords
polypeptide
hydrogen
group
formula
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES497113A
Other languages
English (en)
Other versions
ES497113A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES8301463A1 publication Critical patent/ES8301463A1/es
Publication of ES497113A0 publication Critical patent/ES497113A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA PRODUCCION DE UN POLIPEPTIDO, DE FORMULA GENERAL (I), EN DONDE A ES ALQUILO C <003> O FENILALQUILO C <003> ; A'' ES HIDROGENO; B ES -PHE-; C ES -(L)- O -(D) RP-; D ES -LYS E ES EL RESIDUO DE UN <007>-AMINOACIDO NATURAL; F ES UN GRUPO DE FORMULA: <024>COOR O <024>C OR ; DONDE R ES HIDROGENO O ALQUILO, Y R ES UN ESTER FISIOLOGICAMENTE HIDROLIZABLE; Y E Y SON HIDROGENO O JUNTOS REPRESENTAN UN ENLACE DIRECTO. CONSISTE EN SEPARAR AL MENOS UN GRUPO PROTECTOR DE UN POLIPEPTIDO EN FORMA PROTEGIDA Y QUE TENGA LA SECUENCIA DE LA FORMULA (I), TAL COMO UN GRUPO TERC-BUTILOXICARBONILO O P-METOXIBENCILO PROTECTOR, POR TRATAMIENTO CON TRIS-TRIFLUORACETATO DE BORO, EN PRESENCIA DE TIOANISOL Y UN DISOLVENTE ORGANICO INERTE. DE USO COMO AGENTES FARMACEUTICAMENTE ACTIVOS.
ES497113A 1979-11-27 1980-11-25 Procedimiento para la produccion de un polipeptido Granted ES497113A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1052479 1979-11-27
CH457480 1980-06-13

Publications (2)

Publication Number Publication Date
ES8301463A1 true ES8301463A1 (es) 1982-12-01
ES497113A0 ES497113A0 (es) 1982-12-01

Family

ID=25695798

Family Applications (2)

Application Number Title Priority Date Filing Date
ES497113A Granted ES497113A0 (es) 1979-11-27 1980-11-25 Procedimiento para la produccion de un polipeptido
ES510751A Granted ES510751A0 (es) 1979-11-27 1982-03-24 Procedimiento para la produccion de un polipeptido.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES510751A Granted ES510751A0 (es) 1979-11-27 1982-03-24 Procedimiento para la produccion de un polipeptido.

Country Status (25)

Country Link
US (1) US4395403A (es)
EP (1) EP0029579B1 (es)
JP (1) JPS5690048A (es)
AT (1) ATE2512T1 (es)
AU (1) AU543198B2 (es)
CA (1) CA1182109A (es)
CS (1) CS228140B2 (es)
CY (1) CY1327A (es)
DE (2) DE19375086I2 (es)
DK (1) DK150146C (es)
ES (2) ES497113A0 (es)
FI (1) FI72981C (es)
GR (1) GR71636B (es)
HK (1) HK30686A (es)
HU (1) HU185920B (es)
IE (1) IE50571B1 (es)
IL (1) IL61561A (es)
KE (1) KE3606A (es)
LU (1) LU88344I2 (es)
MY (1) MY8500072A (es)
NL (1) NL930137I2 (es)
NZ (1) NZ195640A (es)
PH (1) PH22841A (es)
PT (1) PT72103B (es)
SG (1) SG8786G (es)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK81082A (da) * 1981-03-06 1982-09-07 Sandoz Ag Fremgangsmaade til fremstilling af polypeptider
CH655505B (es) * 1982-08-24 1986-04-30
US4663435A (en) * 1982-12-06 1987-05-05 Merck & Co., Inc. Bridged cyclic hexapeptide somatostatin analogs
FR2554347B1 (fr) * 1983-11-07 1986-10-03 Immunotech Sa Acide pressinique, ses derives aminoacides substitues et homologues de configuration d ainsi que les derives n- et c- terminal-substitues et leurs applications dans les domaines therapeutique, biologique ou immunologique
US4684620A (en) * 1984-09-04 1987-08-04 Gibson-Stephens Neuropharmaceuticals, Inc. Cyclic polypeptides having mu-receptor specificity
GB8423431D0 (en) * 1984-09-17 1984-10-24 Sandoz Ltd Organic compounds
US4725577A (en) * 1985-04-25 1988-02-16 Administrators Of The Tulane Educational Fund Biologically active lysine containing octapeptides
US4650787A (en) * 1985-04-25 1987-03-17 Schally Andrew Victor Biologically active octapeptides
JPH085913B2 (ja) * 1985-09-12 1996-01-24 ザ・アドミニストレ−タ−ズ・オブ・ザ・ツ−レイン・エデユケイシヨナル・フアンド 治療用ソマトスタチン同族体
GR862206B (en) * 1985-09-12 1986-12-31 Univ Tulane Therapeutic somatostatin analogs
US4904642A (en) * 1985-09-12 1990-02-27 The Administrators Of The Tulane Educational Fund Therapeutic somatostatin analogs
HU198626B (en) * 1986-05-27 1989-11-28 Sandoz Ag Process for producing pharmaceutical compositions comprising somatostatin analogues as active ingredient
US4853371A (en) * 1986-06-17 1989-08-01 The Administrators Of The Tulane Educational Fund Therapeutic somatostatin analogs
GB2193891B (en) * 1986-08-18 1990-07-25 Sandoz Ltd Nasal pharmaceutical composition containing a somatostatin anologue.
DE3726517A1 (de) * 1986-08-18 1988-03-03 Sandoz Ag Nasale zusammensetzungen, welche octreotid enthalten
GB8620035D0 (en) * 1986-08-18 1986-10-01 Sandoz Ltd Organic compounds
HU906341D0 (en) * 1986-10-13 1991-04-29 Sandoz Ag Process for producing peptonic derivatives modified with sugar and pharmaceutical preparatives containing these compounds as active substance
DE3790635B4 (de) * 1986-10-13 2007-11-22 Novartis Ag Verfahren zur Herstellung eines Peptidalkohols und Ausgangsverbindungen dafür
US4871717A (en) * 1987-01-07 1989-10-03 Administrators Of The Tulane Educational Fund Peptides
US5073541A (en) * 1987-11-18 1991-12-17 Administrators Of The Tulane Educational Fund Treatment of small cell lung cancer with somatostatin analogs
ZA895838B (en) * 1988-08-18 1991-03-27 Syntex Inc Pharmaceutical compounds
US5006510A (en) * 1989-06-20 1991-04-09 Ellis Wladislaw V Method for relieving chronic pain with a somatostatin analog composition
HU221294B1 (en) * 1989-07-07 2002-09-28 Novartis Ag Process for producing retarde compositions containing the active ingredient in a polymeric carrier
US5084443A (en) * 1989-12-04 1992-01-28 Biomeasure, Inc. Promoting expression of acetylcholine receptors with lhrh antagonist
ATE140237T1 (de) * 1989-12-08 1996-07-15 Univ Tulane Oktapeptidanaloge von somatostatin mit threonin in position 6
DE69229436T2 (de) * 1991-02-08 1999-11-25 Biomeasure, Inc. Verwendung von somatostatinanalogen zur behandlung von melanomen
US5504069A (en) * 1993-02-11 1996-04-02 Biomeasure, Inc. Inhibition of trauma-induced tumor growth
GB9402767D0 (en) * 1994-02-14 1994-04-06 Sandoz Ltd Improvements in or relating to organic compounds
US5597894A (en) * 1995-06-05 1997-01-28 The Louisiana State University Medical Center Foundation Multi-tyrosinated somatostatin analogs
US5830431A (en) * 1995-06-07 1998-11-03 Mallinckrodt Medical, Inc. Radiolabeled peptide compositions for site-specific targeting
US6355613B1 (en) * 1996-07-31 2002-03-12 Peptor Limited Conformationally constrained backbone cyclized somatostatin analogs
EP0824103A1 (en) * 1996-08-13 1998-02-18 Chang-Shinn Su Method for synthesis of Tyr-3-octreotide
US6262229B1 (en) 1996-12-04 2001-07-17 Biomeasure Incorporated Somatostatin antagonists
US6004928A (en) * 1997-05-13 1999-12-21 Biomeasure, Incorporated Method of treating hyperlipidemia
CA2289499C (en) * 1997-05-13 2010-02-23 Michael Anthony Cawthorne Somatostatin and somatostatin agonists for treating insulin insensitivity and syndrome x
EP0981364B1 (en) * 1997-05-13 2006-03-01 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Method and compositions for treating hyperlipidemia
ES2202864T3 (es) 1997-05-13 2004-04-01 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Agonistas de la somatostatina para disminuir el peso corporal.
ES2144357B1 (es) * 1998-01-29 2000-12-16 Lipotec Sa Procedimiento para la obtencion del analogo de somatostatina octreotide.
US5968903A (en) * 1998-05-07 1999-10-19 Biomeasure, Incorporated Inhibition of H. pylori proliferation
US6159935A (en) 1999-11-29 2000-12-12 Pharmacia & Upjohn Co. Method for preventing diarrhea
RU2196144C1 (ru) * 2001-05-14 2003-01-10 Самуков Владимир Васильевич Защищенные производные октреотида
ATE424414T1 (de) 2001-06-08 2009-03-15 Sod Conseils Rech Applic Chimere somatostatin-dopamin-analoga
EP1490090A4 (en) 2002-02-22 2006-09-20 New River Pharmaceuticals Inc SYSTEMS FOR DELIVERING ACTIVE AGENTS AND METHODS FOR PROTECTING AND DELIVERING ACTIVE AGENTS
US6987167B2 (en) 2002-05-22 2006-01-17 Wockhardt Limited Process for production of the somatostatin analog, octreotide
US20040097419A1 (en) 2002-11-19 2004-05-20 Holger Petersen Organic compounds
PT1511761E (pt) * 2003-04-07 2006-11-30 Novetide Ltd Processo para produção peptídeos cíclicos
EP1624884A4 (en) 2003-04-22 2009-08-05 Ipsen Pharma SOMATOSTATIN VECTORS
EP1709065B1 (en) * 2004-10-04 2010-06-02 Novetide Ltd. A counterion exchange process for peptides
KR101458728B1 (ko) 2005-12-22 2014-11-05 노파르티스 아게 옥트레오티드 및 ２종 이상의 폴리락티드-코-글리콜리드 중합체를 포함하는 서방형 제제
WO2007110765A2 (en) * 2006-03-28 2007-10-04 Wockhardt Ltd Processes for the preparation of octreotide
TW200819137A (en) * 2006-10-31 2008-05-01 Iner Aec Executive Yuan Method for preparation of lipid-spacer radical- reactions of functional group-peptide
US20090082259A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched octreotide
EP2172189A1 (en) 2008-10-01 2010-04-07 Novartis AG Pharmaceutical Compositions
EP2213307A1 (en) 2009-02-03 2010-08-04 Novartis AG Injectable depot formulations
US8377891B2 (en) 2008-11-07 2013-02-19 Usv, Ltd. Process for synthesis of cyclic octapeptide
EP2395987A1 (en) 2009-02-12 2011-12-21 Coöperatieve Mirzorg U.A., Arnhem Use of a combination of diazoxide and metformin for treating obesity or obesity related disorders
US20140296144A1 (en) 2011-09-30 2014-10-02 Mylan Laboratories, Ltd. Process for the preparation of octreotide acetate
CN103102390B (zh) * 2011-11-09 2015-01-28 杭州华津允上医药有限公司 一种奥曲肽的制备方法
WO2013132505A1 (en) 2012-03-09 2013-09-12 Natco Pharma Limited Improved process for preparation of octreotide by solution phase peptide synthesis
JP6869720B2 (ja) 2013-06-13 2021-05-12 アンチセンス セラピューティクス リミテッド 併用療法
CN108395469A (zh) * 2018-02-01 2018-08-14 滨海吉尔多肽有限公司 一种假脯氨酸二肽的合成方法
GB202012334D0 (en) 2020-08-07 2020-09-23 Avon Polymer Prod Ltd Monitoring system

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4105603A (en) * 1977-03-28 1978-08-08 The Salk Institute For Biological Studies Peptides which effect release of hormones
US4139526A (en) * 1977-12-01 1979-02-13 Merck & Co., Inc. Somatostatin analogs
US4140767A (en) * 1977-12-01 1979-02-20 Merck & Co., Inc. Somatostatin analogs
US4190648A (en) * 1979-03-13 1980-02-26 Merck & Co., Inc. Peptides having somatostatin activity
US4225472A (en) * 1979-05-29 1980-09-30 American Home Products Corporation Truncated somatostatin analogs
US4310518A (en) * 1979-10-31 1982-01-12 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs
US4282143A (en) * 1980-06-13 1981-08-04 American Home Products Corporation Octapeptides lowering growth hormone

Also Published As

Publication number Publication date
FI803634L (fi) 1981-05-28
EP0029579B1 (en) 1983-02-16
FI72981B (fi) 1987-04-30
IE802452L (en) 1981-05-27
US4395403A (en) 1983-07-26
ATE2512T1 (de) 1983-03-15
GR71636B (es) 1983-06-20
DE3062075D1 (en) 1983-03-24
HU185920B (en) 1985-04-28
PH22841A (en) 1989-01-19
NL930137I2 (nl) 1997-02-03
ES8305701A1 (es) 1983-04-16
IE50571B1 (en) 1986-05-14
CS228140B2 (en) 1984-05-14
HK30686A (en) 1986-05-09
ES510751A0 (es) 1983-04-16
MY8500072A (en) 1985-12-31
SG8786G (en) 1987-03-27
KE3606A (en) 1986-03-17
DE19375086I2 (de) 2003-01-09
AU543198B2 (en) 1985-04-04
DK150146B (da) 1986-12-15
IL61561A0 (en) 1980-12-31
PT72103A (fr) 1980-12-01
IL61561A (en) 1985-02-28
LU88344I2 (fr) 1994-05-04
DK501980A (da) 1981-05-28
JPS6351159B2 (es) 1988-10-13
AU6468880A (en) 1981-06-04
CA1182109A (en) 1985-02-05
PT72103B (fr) 1982-01-28
ES497113A0 (es) 1982-12-01
FI72981C (fi) 1987-08-10
NL930137I1 (nl) 1993-11-01
JPS5690048A (en) 1981-07-21
CY1327A (en) 1986-06-27
NZ195640A (en) 1984-07-06
EP0029579A1 (en) 1981-06-03
DK150146C (da) 1987-06-01

Similar Documents

Publication Publication Date Title
ES8301463A1 (es) Procedimiento para la produccion de un polipeptido
ES2039278T3 (es) Procedimiento para preparar inhibidores de 5-alfa-reductasa de esteroides.
AR029216A1 (es) Compuestos inhibidores no peptidicos de la union celular dependiente de vla-4 utiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias; composicion farmaceutica y procedimiento de tratamiento
ES2137932T3 (es) Procedimiento para la preparacion de analogos de camptotecina solubles en agua, asi como los compuestos 10-hidroxi-11-alcoxi-6-camptotecina.
ES8602022A1 (es) Un procedimiento para preparar un derivado de 4&#39;-dimetil-4-epipodofilotoxina
BG108806A (en) IIb/IIIa CELL ADHESION INHIIBITORS, METHOD FOR THE PRODUCTION, PHARMACEUTCIAL COMPOSITION AND ADMINISTRATION THEREOF
ES8101077A1 (es) Procedimiento para preparar acidos 3-cefem-4-carboxilicos sustituidos en la posicion 7
ES8706604A1 (es) Un procedimiento para preparar aril-hidroxamatos
CO4950563A1 (es) Nuevos compuestos
ES8705442A1 (es) Un procedimiento para preparar compuestos de carbapenem
ES2117281T3 (es) Nuevos analogos de la vitamina d.
ES2143644T3 (es) Procedimiento para elaborar compuestos antimicrobianos.
ES8404361A1 (es) Un procedimiento para la preparacion de un derivado de cefalosporina.
ES8603497A1 (es) Procedimiento para preparar derivados de cefalosporina
BG101484A (bg) Използване на естери на 3-арилакрилова киселина като средства за защита от светлина и като стабилизатори на нежив органичен материал
MY101132A (en) An optically pure pipecoloxylidide hydrochloride and a process for its preparation
ES8104186A1 (es) Un procedimiento para la preparacion de 9-aminoalquilfluore-no
ES8303427A1 (es) &#34;un procedimiento para preparar compuestos de cefem&#34;.
WO1999003817A3 (en) Aliphatic propargylamines as cellular rescue agents
ES8203848A1 (es) Procedimiento para preparar derivados de acido acetico
ES8301883A1 (es) Procedimiento para la preparacion de derivados de ciclohexe-no
ES8104323A1 (es) Un procedimiento para obtener 2,6-diaminonebularinas
ES8407011A1 (es) Un procedimiento para la preparacion de un derivado de un peptido ciclico a-21978c.
ES8707550A1 (es) Un procedimiento para preparar compuestos peptidicos sustituidos.
ES8300681A1 (es) Procedimiento para preparar amidas.

Legal Events

Date Code Title Description
PC1A Transfer granted